Sphera Funds Management Ltd. 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Sphera Funds Management Ltd. disclosed 108 US equity positions worth $611.2m in its Q3 2024 13F filing. The largest position was TEVA at 6.3% of the reported book, followed by SNY and BBIO.
What did Sphera Funds Management Ltd. own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 6.3% | $38.4m | 2,130,216 | – | |
| 2 | SNY SANOFI | 3.9% | $23.6m | 409,515 | – | ||
| 3 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 3.5% | $21.5m | 842,644 | – | |
| 4 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 3.3% | $19.9m | 1,034,846 | – | |
| 5 | AMZN AMAZON COM INC | Consumer Cyclical | 3.2% | $19.7m | 105,607 | – | |
| 6 | META META PLATFORMS INC | Communication Services | 2.7% | $16.8m | 29,316 | – | |
| 7 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 2.6% | $15.7m | 125,846 | – | |
| 8 | AZN ASTRAZENECA PLC | Healthcare | 2.4% | $14.8m | 190,060 | – | |
| 9 | MSFT MICROSOFT CORP | Technology | 2.4% | $14.4m | 33,427 | – | |
| 10 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 2.3% | $14.2m | 419,103 | – | |
| 11 | AAPL APPLE INC | Technology | 2.3% | $14.2m | 60,847 | – | |
| 12 | NICE NICE LTD | Technology | 2.2% | $13.6m | 78,361 | – | |
| 13 | KURA KURA ONCOLOGY INC | Healthcare | 2.0% | $11.9m | 610,087 | – | |
| 14 | CYTK CYTOKINETICS INC | Healthcare | 1.9% | $11.9m | 225,021 | – | |
| 15 | LLY ELI LILLY & CO | Healthcare | 1.9% | $11.7m | 13,190 | – | |
| 16 | JNJ JOHNSON & JOHNSON | Healthcare | 1.9% | $11.3m | 69,831 | – | |
| 17 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 1.8% | $10.9m | 195,349 | – | |
| 18 | NVMI NOVA LTD | Technology | 1.8% | $10.8m | 51,960 | – | |
| 19 | NVO NOVO-NORDISK A S | Healthcare | 1.5% | $9.3m | 78,080 | – | |
| 20 | TSEM TOWER SEMICONDUCTOR LTD | Technology | 1.5% | $9.3m | 209,441 | – | |
| 21 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 1.4% | $8.8m | 152,307 | – | |
| 22 | VKTX VIKING THERAPEUTICS INC | Healthcare | 1.4% | $8.4m | 133,066 | – | |
| 23 | HELP CYBIN INC | 1.4% | $8.3m | 933,225 | – | ||
| 24 | IMTX IMMATICS N.V | Healthcare | 1.3% | $8.2m | 721,111 | – | |
| 25 | PHVS PHARVARIS N V | 1.3% | $8.1m | 439,292 | – | ||
| 26 | CATX PERSPECTIVE THERAPEUTICS INC | 1.3% | $7.9m | 589,295 | – | ||
| 27 | CHECK POINT SOFTWARE TECH LT | 1.3% | $7.8m | 40,215 | – | ||
| 28 | ABBV ABBVIE INC | Healthcare | 1.2% | $7.5m | 38,000 | – | |
| 29 | MERUS N V | 1.2% | $7.4m | 147,633 | – | ||
| 30 | ENPH ENPHASE ENERGY INC | Technology | 1.2% | $7.3m | 64,224 | – | |
| 31 | MRK MERCK & CO INC | Healthcare | 1.1% | $6.8m | 59,600 | – | |
| 32 | BHVN BIOHAVEN LTD | Healthcare | 1.1% | $6.7m | 133,323 | – | |
| 33 | S SENTINELONE INC | Technology | 1.1% | $6.6m | 276,554 | – | |
| 34 | MRVL MARVELL TECHNOLOGY INC | Technology | 1.0% | $6.3m | 87,611 | – | |
| 35 | INOZYME PHARMA INC | 1.0% | $6.2m | 1,191,140 | – | ||
| 36 | APLSUSD APELLIS PHARMACEUTICALS INC | 1.0% | $6.2m | 215,873 | – | ||
| 37 | SKYE SKYE BIOSCIENCE INC | 1.0% | $6.1m | 1,563,522 | – | ||
| 38 | NTLA INTELLIA THERAPEUTICS INC | Healthcare | 1.0% | $6.0m | 291,080 | – | |
| 39 | RZLT REZOLUTE INC | 0.9% | $5.8m | 1,196,938 | – | ||
| 40 | NVS NOVARTIS AG | Healthcare | 0.9% | $5.8m | 50,000 | – | |
| 41 | WIX WIX COM LTD | Technology | 0.9% | $5.7m | 34,253 | – | |
| 42 | VIGL VIGIL NEUROSCIENCE INC | 0.9% | $5.6m | 1,647,604 | – | ||
| 43 | ORMAT TECHNOLOGIES INC | 0.9% | $5.3m | 5,037,000 | – | ||
| 44 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 0.8% | $4.8m | 347,627 | – | ||
| 45 | BIIB BIOGEN INC | Healthcare | 0.8% | $4.7m | 24,455 | – | |
| 46 | PTCT PTC THERAPEUTICS INC | Healthcare | 0.7% | $4.4m | 118,345 | – | |
| 47 | RCKT ROCKET PHARMACEUTICALS INC | Healthcare | 0.7% | $4.3m | 231,792 | – | |
| 48 | GSK GSK PLC | Healthcare | 0.7% | $4.1m | 100,000 | – | |
| 49 | ETNBGBP 89BIO INC | 0.6% | $4.0m | 536,547 | – | ||
| 50 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 0.6% | $3.9m | 252,539 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.